Immunomedics (IMMU) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: idahoranch1 who wrote (299)	12/19/2004 4:21:00 PM
From: kitty2	Read Replies (1) of 371

idahoranch1 Is rituxin currently being used off label for lupus are any other approved drugs being used off label for lupus does immu have a lead time edge over any other company trying to get a product out for lupus immu has a bad habit of allowing competition to speed past them often with similar products. what is the chance of this happening It seems apparent that immu must get a deal of some kind in the next 3 months for cd22lupus trial phase 3. if immu gets deal based on your experience what would stock level per share go to? I feel very foolish with my immu position. I am very long thanks kitty 2 why does not the owner of rituxin do trial for lupus and get that indication also

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next